NCT05427461Active, not recruiting
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2
Source: ClinicalTrials.gov · Last updated 3 Jun 2025
Brief summary (registry, in English)
Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating "cancer cell/macrophage" hybrid cells in the peripheral blood and the evolution of this rate over time. The study will be conducted on a population of patients with leiomyosarcoma and treated in the context of routine care. 20 patients will be included: * 10 patients with localized disease. * 10 patients with metastatic disease. For each included patient, blood samples will be collected during baseline visit and up to 24 months after inclusion.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 16 Jun 2022
- Start date
- Jan 2023
- Primary completion date
- Jul 2026
- Lead sponsor
- Institut Claudius Regaud
- Diseases
- Sarcoma
- NCT number
- NCT05427461
What you commit to
- Study type: Interventional
- Planned participants: 20
- From Jan 2023 to the primary completion date, Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any psychological, family, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures provided for in the study protocol.
Other
- Diagnosis of any other histological subtype of soft tissue sarcoma
- Associated pathology(ies) that may interfere with the study procedure
- Pregnant or breastfeeding woman
- Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Who the study is looking for
- Patient with leiomyosarcoma.
- Diagnosis of sarcoma histologically confirmed by the RRePS network (Réseau de Référence en Pathologie des Sarcomes et des Viscères)
- Localized or metastatic disease
- Newly diagnosed patient who has not yet initiated specific treatment for sarcoma
- Age ≥ 18 years
- Patient affiliated to a Social Security system in France.
- Patient having signed informed consent prior to inclusion in the study and prior to any specific study procedures
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut Universitaire du Cancer Toulouse - Oncopole Coordinator of this site? Confirm its status | Toulouse | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.